Companies / EMD

EMYRIA LIMITED

ASX:EMDHealth Care Equipment & Services
806.6M shares on issueASX (delayed) · as of 28 July 2026$0.048price · delayed$35.5Mmarket cap · indicative
D
Dilution grade

Share count grew 97% in 24 months; 3 cash raises in 24 months; options/rights overhang 82% of shares

Cash runway5.8 quarters of funding
Share-count growth (24m)97.2%
Raise cadence (24m)3 cash raises
Options & rights overhang81.8% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

EMYRIA LIMITED's ordinary share count grew 97.2% between May 2024 and May 2026, to 807M shares. The company raised capital three times in that period for total disclosed proceeds of A$14.5M, most recently A$8.0M in November 2025. Options and rights on issue could convert into 659M new shares, equal to 81.8% of the current share count, with 0% in the money at the current share price and the nearest expiry in August 2026. At the March 2026 quarter the company reported A$7.4M in available cash, about 5.8 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
81.8%
Max option dilution
0.0%
ITM option dilution
1
Raises · last 12 months
5.8 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 806.6M per ASX (delayed) (28 July 2026).
497.5M611.0M724.4MDec 24Sept 25July 26Cash raise · 17 Nov 2025Cash raise · 13 June 2025

Cash runway

5.8 qtrs
More than four quarters of funding at the recent spend rate.
$7.4M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
8 June 20263H · cancellationEMD : ORDINARY FULLY PAID806.6MAppendix 3H
29 May 20262A · quoted issueEMD : ORDINARY FULLY PAID806.6MAppendix 2A
29 May 20263G · unquotedEMD : ORDINARY FULLY PAID806.6MAppendix 3G
16 Feb 20262A · quoted issueEMD : ORDINARY FULLY PAID806.6MAppendix 2A
6 Feb 20262A · quoted issueEMD : ORDINARY FULLY PAID806.5MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

3 cash raises in the last 24 months · 1 in the last 12 months

$8.0M
Capital raise
17 Nov 2025
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

81.8%
Total overhang · of current shares
0.0%
In the money · at current price
659.5M
Potential new shares
Aug 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
28 May 2026Dr Michael WinloOther———3Y notice
28 May 2026Mr Greg HutchinsonOther———3Y notice
9 Jan 2026Mohit KaushalOther2.0M——3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

26 July 2026Techknow Invest Roadshow Company Presentation
21 July 2026EMD to Present at Addressing the Mental Health Crisis Event
15 July 2026Emyria to Present at Upcoming Investor and Industry Events
23 June 2026$PEmyria Depression Program Shows Positive Results
21 June 2026$PEmyria Confirms NSW Workforce Ahead of Clinic Opening
15 June 2026Emyria Company Update - Video Presentation
10 June 2026$PEmyria Company Update Presentation
8 June 2026Notification of cessation of securities - EMD
29 May 2026Change of Director's Interest Notice x 2
29 May 2026Notification regarding unquoted securities - EMD
29 May 2026Application for quotation of securities - EMD
27 May 2026$PTGA Update to Accelerate Empax Therapist Recruitment
17 May 2026$PEmyria Activates First Victorian Empax Clinic
4 May 2026$PMarch Quarter Investor Video Presentation
1 May 2026Results of General Meeting
28 Apr 2026$PEmyria Extends National Expansion into New South Wales
27 Apr 2026$PMarch 2026 Quarterly Activities Report and Appendix 4C
20 Apr 2026Ignite Investment Summit Singapore Presentation
19 Apr 2026$PEmyria Launches Global Partnership Program
1 Apr 2026$PEMD Commences NSW Workforce Recruitment To Support Expansion

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.